pubmed-article:16782926 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:16782926 | lifeskim:mentions | umls-concept:C0008976 | lld:lifeskim |
pubmed-article:16782926 | lifeskim:mentions | umls-concept:C0278996 | lld:lifeskim |
pubmed-article:16782926 | lifeskim:mentions | umls-concept:C1522449 | lld:lifeskim |
pubmed-article:16782926 | lifeskim:mentions | umls-concept:C0034656 | lld:lifeskim |
pubmed-article:16782926 | lifeskim:mentions | umls-concept:C0221910 | lld:lifeskim |
pubmed-article:16782926 | lifeskim:mentions | umls-concept:C1707455 | lld:lifeskim |
pubmed-article:16782926 | lifeskim:mentions | umls-concept:C0205390 | lld:lifeskim |
pubmed-article:16782926 | lifeskim:mentions | umls-concept:C0439858 | lld:lifeskim |
pubmed-article:16782926 | pubmed:issue | 18 | lld:pubmed |
pubmed-article:16782926 | pubmed:dateCreated | 2006-6-19 | lld:pubmed |
pubmed-article:16782926 | pubmed:abstractText | With the aim to increase the dose intensity of radiation therapy (RT), and subsequently the locoregional control rate, a very accelerated RT regimen was compared with conventional RT in a series of patients with head and neck squamous cell carcinoma (HNSCC). | lld:pubmed |
pubmed-article:16782926 | pubmed:language | eng | lld:pubmed |
pubmed-article:16782926 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16782926 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:16782926 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:16782926 | pubmed:month | Jun | lld:pubmed |
pubmed-article:16782926 | pubmed:issn | 1527-7755 | lld:pubmed |
pubmed-article:16782926 | pubmed:author | pubmed-author:BourhisJeanJ | lld:pubmed |
pubmed-article:16782926 | pubmed:author | pubmed-author:VerrellePierr... | lld:pubmed |
pubmed-article:16782926 | pubmed:author | pubmed-author:LemanskiClair... | lld:pubmed |
pubmed-article:16782926 | pubmed:author | pubmed-author:BardetEtienne... | lld:pubmed |
pubmed-article:16782926 | pubmed:author | pubmed-author:TortochauxJac... | lld:pubmed |
pubmed-article:16782926 | pubmed:author | pubmed-author:JulieronMorbi... | lld:pubmed |
pubmed-article:16782926 | pubmed:author | pubmed-author:LapeyreMichel... | lld:pubmed |
pubmed-article:16782926 | pubmed:author | pubmed-author:LusinchiAntoi... | lld:pubmed |
pubmed-article:16782926 | pubmed:author | pubmed-author:RivesMichelM | lld:pubmed |
pubmed-article:16782926 | pubmed:author | pubmed-author:BenhamouEllen... | lld:pubmed |
pubmed-article:16782926 | pubmed:author | pubmed-author:WibaultPierre... | lld:pubmed |
pubmed-article:16782926 | pubmed:author | pubmed-author:GeoffroisLion... | lld:pubmed |
pubmed-article:16782926 | pubmed:author | pubmed-author:BourdinSylvai... | lld:pubmed |
pubmed-article:16782926 | pubmed:author | pubmed-author:LuboinskiMoni... | lld:pubmed |
pubmed-article:16782926 | pubmed:author | pubmed-author:AghiliMehdiM | lld:pubmed |
pubmed-article:16782926 | pubmed:author | pubmed-author:LesaunierFran... | lld:pubmed |
pubmed-article:16782926 | pubmed:author | pubmed-author:BenassiToufik... | lld:pubmed |
pubmed-article:16782926 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:16782926 | pubmed:day | 20 | lld:pubmed |
pubmed-article:16782926 | pubmed:volume | 24 | lld:pubmed |
pubmed-article:16782926 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:16782926 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:16782926 | pubmed:pagination | 2873-8 | lld:pubmed |
pubmed-article:16782926 | pubmed:meshHeading | pubmed-meshheading:16782926... | lld:pubmed |
pubmed-article:16782926 | pubmed:meshHeading | pubmed-meshheading:16782926... | lld:pubmed |
pubmed-article:16782926 | pubmed:meshHeading | pubmed-meshheading:16782926... | lld:pubmed |
pubmed-article:16782926 | pubmed:meshHeading | pubmed-meshheading:16782926... | lld:pubmed |
pubmed-article:16782926 | pubmed:meshHeading | pubmed-meshheading:16782926... | lld:pubmed |
pubmed-article:16782926 | pubmed:year | 2006 | lld:pubmed |
pubmed-article:16782926 | pubmed:articleTitle | Phase III randomized trial of very accelerated radiation therapy compared with conventional radiation therapy in squamous cell head and neck cancer: a GORTEC trial. | lld:pubmed |
pubmed-article:16782926 | pubmed:affiliation | Institut Gustave Roussy, Radiation Oncology, Head and Neck Statistics Department, Villejuif, France. bourhis@igr.fr | lld:pubmed |
pubmed-article:16782926 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:16782926 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
pubmed-article:16782926 | pubmed:publicationType | Clinical Trial, Phase III | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16782926 | lld:pubmed |